French Biotech Stocks

Sanofi

Market Cap: €113.9b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Eurofins Scientific

Market Cap: €10.3b

Provides various analytical testing and laboratory services worldwide.

Ipsen

Market Cap: €8.6b

Operates as a biopharmaceutical company worldwide.

Virbac

Market Cap: €2.6b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.

Vetoquinol

Market Cap: €876.4m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

MedinCell

Market Cap: €515.1m

A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.

Valneva

Market Cap: €480.7m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Boiron

Market Cap: €427.1m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Euroapi

Market Cap: €260.9m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use.

Eurobio Scientific Société anonyme

Market Cap: €254.4m

Engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer.

Genfit

Market Cap: €191.1m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Innate Pharma

Market Cap: €180.6m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

OSE Immunotherapeutics

Market Cap: €138.4m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Eurofins-Cerep

Market Cap: €103.9m

Provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.

Cellectis

Market Cap: €96.7m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

MaaT Pharma

Market Cap: €80.4m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Novacyt

Market Cap: €32.7m

Develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.

genOway Société anonyme

Market Cap: €29.7m

A biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide.

Aelis Farma

Market Cap: €17.1m

A clinical-stage biotechnology company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders.

Valbiotis

Market Cap: €17.0m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

Nicox

Market Cap: €15.6m

Operates as an ophthalmology company in France and internationally.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

Plant Advanced Technologies

Market Cap: €12.3m

A plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France.

IntegraGen

Market Cap: €4.3m

Provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France.

PHAXIAM Therapeutics

Market Cap: €2.9m

A biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States.

Neovacs

Market Cap: €10.3k

A biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France.